Diagnostic Accuracy of Diffusion Weighted Magnetic Resonance Imaging.docx
Main Article Content
Keywords
urinary bladder cancer, diffusion weighted magnetic resonance imaging, sensitivity.
Abstract
Objectives: To determine the diagnostic accuracy of diffusion weighted magnetic resonance imaging in diagnosing urinary bladder carcinoma, taking histopathology as gold standard.
Methodology: This study was conducted at Department of Diagnostic Radiology & Department of Urology, Sheikh Zayed Hospital, Rahim Yar Khan from February 2019 to July 2019. A total of 162 patients presenting with hematuria (RBCs >100 on urine complete examination) and presence of irregular soft tissue structure projecting into bladder lumen from a fixed mural site on ultrasonography and age 20-60 years of either gender were included. Patients with operated for urinary bladder cancer, biopsy proven urinary bladder carcinoma and any contraindication to MRI were excluded. All the patients were then undergoing DW-MRI and presence or absence of urinary bladder carcinoma is noted. The DW-MRI findings were correlated with histopathology findings.
Results: In DW-MRI positive patients, 74 (True Positive) had urinary bladder cancer and 11 (False Positive) had no urinary bladder cancer on histopathology. Among 77, DW-MRI negative patients, 01 (False Negative) had urinary bladder cancer on histopathology whereas 76 (True Negative) had no urinary bladder cancer on histopathology (p=0.0001). Overall sensitivity, specificity, positive predictive value, negative predictive value and diffusion weighted magnetic resonance imaging in diagnosing urinary bladder carcinoma, taking histopathology as gold standard was 98.67%, 87.36%, 87.06%, 98.70% and 92.59% respectively.
Conclusion: This study concluded that DW-MRI is a highly sensitive and accurate non-invasive modality for diagnosing urinary bladder cancer.
References
2. Yoshida S, Koga F, Kobayashi S, Tanaka H, Satoh S, Fujii Y, et al. Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol. 2014;6(6):344–54.
3. Abdel-Rahmana HM, El Fikia IM, Desokyb EAE, Elsayedb ER, Abd Samad KM. The role of diffusion-weighted magnetic resonance imaging in T staging and grading of urinary bladder cancer. Egyptian J Radiol Nuclear Med. 2015;46(3):741–47.
4. Teama AH, Darweesh AN, Abol-Enin HA, Abouelkheir RT. Role of multidetector computed tomography virtual cystoscopy in evaluation of urinary bladder carcinoma. Egyptian J Radiol Nuclear Med. 2014;45:543–54.
5. Amin MF, Abd El Hamid AM. The diagnostic accuracy of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the early detection and evaluation of bladder carcinoma: comparison with conventional cystoscopy. Abdom Imaging. 2013;38(1):184–92.
6. Maurer T, Horn T, Heck M, Gschwend JE, Eiber M, Beer AJ. Current staging procedures in urinary bladder cancer. Diagnos. 2013;3:315-24.
7. Yamada Y, Kobayashi S, Isoshima S, Arima K, Sakuma H, Sugimura Y. The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis. J Can Res Ther. 2014;10:878-82.
8. Gupta N, Sureka B, Kumar MM, Malik A, Bhushan TB, Mohanty N K. Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation. Urol Ann. 2015;7:199-204.
9. Zhai N, Wang H, Zhu LM, Wang JH, Sun XH, Hu XB, et al. Sensitivity and specificity of diffusion-weighted magnetic resonance imaging in diagnosis of bladder cancers. Clin Invest Med. 2015;38(4):E173-E184.
10. Ceylan K, Taken K, Gecit I, Pirincci N, Gunes M, Tanik S, et al. Comparison of cystoscopy with diffusion-weighted magnetic resonance images used in the diagnosis and follow-up of patients with bladder tumors. Asian Pac J Cancer Prev. 2010;11(4):1001-4.
11. Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Dbulutand M. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol. 2011;84:875–82.
12. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 2009;251:415–21.
13. Yamada Y, Kobayashi S, Isoshima S, Arima K, Sakuma H, Sugimura Y. The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis. J Can Res Ther 2014;10:878-82
14. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 2009; 251:415–421. Back to cited text no. 10
15. El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. BJU Int 2012; 110(Pt B): 622–627.
16. Sevcenco S, Haitel A, Ponhold L, Susani M, Fajkovic H. Quantitative apparent diffusion coefficient measurements obtained by 3-tesla mri are correlated with biomarkers of bladder cancer proliferative activity. PLoS ONE. 2014;9(9):e106866.
17. Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Dbulutand M. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol. 2011;84:875–82.